Fundraising FoxLevel Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Enveda operates a drug-discovery platform that analyzes natural samples—primarily plant-derived molecules—using mass spectrometry, AI foundation models, and automated high-throughput labs to identify their chemical structures and therapeutic properties.
AI & Machine LearningBiotechDeep TechBoulder, US
Viswa Colluru, PhD(Founder)inViswa Colluru(Executive Officer, Director)inDaniel Wee(Executive Officer)
BoardRohit Sharma(Director)Zavain Dar(Director)inBruce Beutel(Director)
PartnerSari Azout· solo GP
Co-investorsAir Street CapitalBoulder VenturesCatalio Capital Management, LPFPVHummingbird VenturesJAZZ Venture Partners+15 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.